WCM Investment Management LLC Cuts Position in Addus HomeCare Co. (NASDAQ:ADUS)

WCM Investment Management LLC cut its stake in Addus HomeCare Co. (NASDAQ:ADUS) by 5.4% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 471,615 shares of the company’s stock after selling 26,664 shares during the period. WCM Investment Management LLC owned about 2.60% of Addus HomeCare worth $59,556,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in ADUS. Wasatch Advisors LP grew its position in Addus HomeCare by 11.8% in the third quarter. Wasatch Advisors LP now owns 1,043,240 shares of the company’s stock worth $138,782,000 after acquiring an additional 110,010 shares in the last quarter. Principal Financial Group Inc. boosted its position in Addus HomeCare by 17.5% during the third quarter. Principal Financial Group Inc. now owns 505,853 shares of the company’s stock valued at $67,293,000 after buying an additional 75,409 shares during the period. Harbor Capital Advisors Inc. boosted its position in Addus HomeCare by 127.7% during the third quarter. Harbor Capital Advisors Inc. now owns 64,311 shares of the company’s stock valued at $8,555,000 after buying an additional 36,071 shares during the period. Barclays PLC boosted its position in Addus HomeCare by 204.8% during the third quarter. Barclays PLC now owns 43,470 shares of the company’s stock valued at $5,783,000 after buying an additional 29,207 shares during the period. Finally, Geode Capital Management LLC boosted its position in Addus HomeCare by 7.1% during the third quarter. Geode Capital Management LLC now owns 423,934 shares of the company’s stock valued at $56,406,000 after buying an additional 28,284 shares during the period. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Addus HomeCare

In other Addus HomeCare news, CEO R Dirk Allison sold 12,500 shares of the stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the transaction, the chief executive officer now owns 141,897 shares in the company, valued at approximately $17,476,034.52. This represents a 8.10 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Roberton James Stevenson sold 2,250 shares of the stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $121.00, for a total value of $272,250.00. Following the transaction, the executive vice president now owns 10,217 shares in the company, valued at $1,236,257. This represents a 18.05 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 39,750 shares of company stock worth $4,930,750 over the last quarter. 4.60% of the stock is currently owned by insiders.

Addus HomeCare Stock Performance

Shares of Addus HomeCare stock opened at $116.10 on Friday. The stock has a market cap of $2.10 billion, a price-to-earnings ratio of 26.57, a price-to-earnings-growth ratio of 1.55 and a beta of 1.00. The stock has a 50 day moving average price of $126.76 and a 200-day moving average price of $127.35. Addus HomeCare Co. has a one year low of $85.94 and a one year high of $136.72.

Analysts Set New Price Targets

Several research firms have issued reports on ADUS. Macquarie restated an “outperform” rating and set a $139.00 price target on shares of Addus HomeCare in a research report on Monday, November 4th. JMP Securities began coverage on shares of Addus HomeCare in a research report on Monday, December 16th. They set an “outperform” rating and a $150.00 price target for the company. Citizens Jmp upgraded shares of Addus HomeCare to a “strong-buy” rating in a research report on Monday, December 16th. Stephens upped their price objective on shares of Addus HomeCare from $143.00 to $145.00 and gave the company an “overweight” rating in a research note on Wednesday, November 6th. Finally, StockNews.com raised shares of Addus HomeCare from a “hold” rating to a “buy” rating in a research note on Friday, January 24th. One investment analyst has rated the stock with a sell rating, eight have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus target price of $134.22.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.